Dual role of glutathione in selenite-induced oxidative stress and apoptosis in human hepatoma cells

Free Radical Biology and Medicine

Volumn 28, Issue 7, 2000, Pages 1115-1124

  Shen, Han Ming ^a   Yang, Cheng Feng ^a   Liu, Jin ^a   Ong, Choon Nam ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Cancer; Free radicals; Glutathione; Oxidative stress; Selenite; Selenium

Indexed keywords

ACETYLCYSTEINE; FREE RADICAL; GLUTATHIONE; SELENITE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; GLUTATHIONE METABOLISM; HEPATOMA CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACETYLCYSTEINE; APOPTOSIS; BUTHIONINE SULFOXIMINE; CARCINOMA, HEPATOCELLULAR; GLUTATHIONE; GROWTH INHIBITORS; HUMANS; INTRACELLULAR FLUID; L-LACTATE DEHYDROGENASE; LIVER NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SODIUM SELENITE; TUMOR CELLS, CULTURED;

EID: 0034069821     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00206-9     Document Type: Article

References (49)

1. Combs G.F. Jr, Gray W.P. Chemopreventive agents selenium. Pharmacol. Ther. 79:1998;179-192.
2. Ip C. Lessons from basic research in selenium and cancer prevention. J. Nutr. 128:1998;1845-1854.
3. Ganther H.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention complexities with thioredoxin reductase. Carcinogenesis. 20:1999;1657-1666.
4. Lanfear J., Flemming J.J., Wu L., Webster G., Harrson P.R. The selenium metabolite selenodiglutathione induces p53 and apoptosis relevance to the chemopreventive effects of selenium? Carcinogenesis. 15:1994;1387-1396.
5. Lu J., Kaeck M., Jiang C., Wilson A.C., Thompson H.J. Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem. Pharmacol. 47:1994;1531-1535.
6. Thompson H.J., Wilson A., Lu J., Singh M., Jiang C., Upadhyyaya P., El-Bayoumy K., Ip C. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis. 15:1994;183-186.
7. 2 toxicity. Carcinogenesis. 16:1995;1579-1584.
8. Stewart M.S., Davis R.L., Walsh L.P., Pence B.C. Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29). Cancer Lett. 117:1997;35-40.
9. Stewart M.S., Spallhoz J.E., Neldner K.H., Pence B.C. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic. Biol. Med. 26:1999;42-48.
10. 2 cells. Int. J. Cancer. 81:1999;820-828.
11. Tamura T., Stadtman T.C. A new selenoprotein from human lung adenocarcinoma cell purification, properties, and thioredoxin reductase activity. Proc. Natl. Acad. Sci. USA. 93:1996;1006-1011.
12. Powis G., Gasdaska J.R., Gasdaska P.Y., Berggren M., Kirkpatrick D.L., Engman L., Cotgreave I.A., Angulo M., Baker A. Selenium and the thioredoxin redox system effects on cell growth and death. Oncol. Res. 9:1997;303-312.
13. Batist G., Katki A.G., Klecker R.W. Jr, Myers C.E. Selenium-induced cytotoxicity of human leukemia cells interaction with reduced glutathione. Cancer Res. 46:1986;5482-5485.
14. Stadtman T.C. Selenocysteine. Annu. Rev. Biochem. 65:1996;83-100.
15. Seko Y., Saito Y., Kitahara J., Imura N. Active oxygen generation by the reaction of selenite with reduced glutathione in vitro. Wendel A. Selenium in biology and medicine. 1989;70-73 Springer-Verlag, Berlin.
16. Seko Y., Imura N. Active oxygen generation as a possible mechanism of selenium toxicity. Biomed. Environ. Sci. 10:1997;333-339.
17. Yan L., Spallholz J.E. Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Biochem. Pharmacol. 45:1993;429-437.
18. Spallholz J.E. On the nature of selenium toxicity and carcinostatic activity. Free Radic. Biol. Med. 17:1994;45-64.
19. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
20. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res. 54:1994;1968s-1975s.
21. 1-induced cell injury in cultured rat hepatocytes. Toxicology. 99:1995;115-123.
22. 2 cells. Biochem. Pharmacol. 57:1999;273-279.
23. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
24. Van Klaveren R.J., Demedts M., Nemery B. Cellular glutathione turnover in vitro, with emphasis on type II pneumocytes. Eur. Respir. J. 10:1997;1392-1400.
25. Deneke S.M., Fanburg B.L. Regulation of cellular glutathione. Am. J. Physiol. 257:1989;L163-L173.
26. Anderson M.E. Glutathione an overview of biosynthesis and modulation. Chem. Biol. Interact. 111-112:1998;1-14.
27. Cotgreave I.A. N-acetylcysteine pharmacological considerations and experimental and clinical applications. Adv. Pharmacol. 38:1997;205-227.
28. Kuchan M.J., Milner J.A. Influence of supplemental glutathione on selenite-mediated growth inhibition of canine mammary cells. Cancer Lett. 57:1991;181-186.
29. Kuchan M.J., Milner J.A. Influence of intracellular glutathione on selenite-mediated growth inhibition of canine mammary tumor cells. Cancer Res. 52:1992;1091-1095.
30. Yan L., Yee J.A., Boylan L.M., Spallholz J.E. Effect of selenium compounds and thiols on human mammary tumor cells. Biol. Trace Elem. Res. 30:1991;145-162.
31. Caffrey P.B., Frenkel G.D. Selenite cytotoxicity in drug resistant and nonresistant human ovarian tumor cells. Cancer Res. 52:1992;4812-4816.
32. Frenkel G., Falvey D. Evidence for the involvement of cellular sulfhydryl compounds in the inhibition of DNA synthesis by selenite. Mol. Pharmacol. 34:1988;573-577.
33. Frenkel G., Falvey D. Involvement of sulfhydryl compounds in the inhibition of cellular RNA synthesis by selenite. Biochem. Pharmacol. 38:1989;2849-2852.
34. Caffrey P.B., Frenkel G.D. Inhibition of cell colony formation by selenite involvement of glutathione. Mol. Pharmacol. 39:1991;281-284.
35. Kitahara J., Seko Y., Imura N. Possible involvement of active oxygen species in selenite toxicity in isolated rat hepatocytes. Arch. Toxicol. 67:1993;497-501.
36. De Flora S., Cesarone C.F., Balansky R.M., Albini A., D'Agostini F., Bennicelli C., Bagnasco M. Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background. J. Cell. Biochem. 22:(Suppl.):1995;33-41.
37. Aruoma O.I., Halliwell B., Hoey B.M., Bulter J. The antioxidant action of N-acetylcysteine its reaction with hydrogen peroxide, hydroxyl radical, superoxide, an hypochlorous acid. Free Radic. Biol. Med. 6:1989;593-597.
38. Villagrasa V., Cortijo J., Marti-Cabrera M., Ortiz J.L., Berto L., Esteras A., Bruseghini L., Morcillo E.J. Inhibitory effects of N-acetylcysteine on superoxide anion generation in human polymorphonuclear leukocytes. J. Pharm. Pharmacol. 49:1997;525-529.
39. Li Y., Zhu H., Kuppusamy P., Roubaud V., Zweier J.L., Trush M.A. Validation of lucigenin(bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J. Biol. Chem. 273:1998;2015-2023.
40. Chang T.C., Chang M., Hsueh S. Glutathione concentration and distribution in cervical cancers and adjacent normal tissues. Gynecol. Obstet. Invest. 36:1993;52-55.
41. Perry R.R., Mazetta B.S., Levin M., Barranco S.C. Glutathione levels and viability in breast tumors and normal tissue. Cancer. 72:1993;783-787.
42. Butler R.N., Bulter W.J., Moraby Z., Fettman M.J., Khoo K.K., Roberts-Thomson I.C. Glutathione concentrations and glutathione S-transferase activity in human colonic neoplasms. J. Gastroenterol. Hepatol. 9:1994;60-63.
43. Blair S.L., Heerdt P., Sachar S., Abolhoda A., Hochwald S., Cheng H., Burt M. Glutathione metabolism in patients with non-small cell lung cancers. Cancer Res. 57:1997;152-155.
44. Coban T., Mabsout A., Eke B.C., Bulbul D., Berberoglu U., Iscan M. Glutathione and lipid peroxidation levels in human breast tumors. Neoplasma. 45:1998;151-156.
45. Wolf C., Lewis A., Carmichael J., Adams D., Allan D., Ansel D. The role of glutathione in determining the response of normal and tumour cells to anticancer drugs. Biochem. Soc. Trans. 15:1987;728-730.
46. Hosking L., Whelan R., Shellard S., Bedford P., Hill B. An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines. Biochem. Pharmacol. 40:1990;1833-1842.
47. Medina D., Oborn C.J. Differential effects of selenium on the growth of mouse mammary cells in vitro. Cancer Lett. 13:1981;333-344.
48. Fico M.E., Poirier K.A., Watrach A.M., Watrach M.A., Milner J.A. Differential effects of selenium on normal and neoplastic canine mammary cells. Cancer Res. 46:1986;3384-3388.
49. Caffrey P.B., Frenkel G.D. The development of drug resistance by tumor cells in vitro accompanied by the development of sensitivity to selenite. Cancer Lett. 81:1994;59-65.